New Approach For Simvastatin As An Antibacterial: Synergistic Effect With Bio-Synthesized Silver Nanoparticles Against Multidrug-Resistant Bacteria

References

• O’Neill J. Tackling drug-resistant infections globally: final report and recommendations. Rev Antimicrob Resist. 2016;1–80.
   Google Scholar
• Cantas L, Shah SQA, Cavaco LM, et al. A brief multi-disciplinary review on antimicrobial resistance in medicine and its linkage to the global environmental microbiota. Front Microbiol. 2013;4:1–14. doi:10.3389/fmicb.2013.0007723346082
   PubMed Web of Science ®Google Scholar
• Silva KC, Lincopan N. Epidemiologia das betalactamases de espectro estendido no Brasil: impacto clínico e implicações para o agronegócio. J Bras Patol E Med Lab. 2012;48(2):91–99. doi:10.1590/S1676-24442012000200004
   Google Scholar
• Bodnar GC, Martins HM, De Oliveira CF, et al. Comparison of HRM analysis and three REP-PCR genomic fingerprint methods for rapid typing of MRSA at a Brazilian hospital. J Infect Dev Ctries. 2016;10(12):1306–1317. doi:10.3855/jidc.788728036310
   PubMed Web of Science ®Google Scholar
• Graziano TS, Cuzzullin MC, Franco GC, et al. Statins and antimicrobial effects: simvastatin as a potential drug against Staphylococcus aureus biofilm. PLoS One. 2015;10(5):1–17. doi:10.1371/journal.pone.0128098
   Web of Science ®Google Scholar
• Friesen JA, Rodwell VW. The 3-hydroxy-3-methylglutaryl coenzyme-A (HMG-CoA) reductases. Genome Biol. 2004;5(11):248. doi:10.1186/gb-2004-5-11-24815535874
   PubMed Web of Science ®Google Scholar
• Jain MK, Ridker PM. Anti-inflammatory effects of statins: clinical evidence and basic mechanisms. Nat Rev Drug Discov. 2005;4(12):977–987. doi:10.1038/nrd187616341063
   PubMed Web of Science ®Google Scholar
• Jerwood S, Cohen J. Unexpected antimicrobial effect of statins. J Antimicrob Chemother. 2008;61(2):362–364. doi:10.1093/jac/dkm49618086693
   PubMed Web of Science ®Google Scholar
• Chen X, Schluesener HJ. Nanosilver: a nanoproduct in medical application. Toxicol Lett. 2008;176(1):1–12. doi:10.1016/j.toxlet.2007.10.00418022772
   PubMed Web of Science ®Google Scholar
• Ansari MA, Khan HM, Khan AA, Cameotra SS, Saquib Q, Musarrat J. Gum arabic capped-silver nanoparticles inhibit biofilm formation by multi-drug resistant strains of Pseudomonas aeruginosa. J Basic Microbiol. 2014;54(7):688–699. doi:10.1002/jobm.v54.724403133
   PubMed Web of Science ®Google Scholar
• Bibbs RK, Harris RD, Peoples VA, et al. Silver polyvinyl pyrrolidone nanoparticles exhibit a capsular polysaccharide influenced bactericidal effect against Streptococcus pneumoniae. Front Microbiol. 2014;5:1–8. doi:10.3389/fmicb.2014.0054724478763
   PubMed Web of Science ®Google Scholar
• Cardozo VF, Oliveira AG, Nishio EK, et al. Antibacterial activity of extracellular compounds produced by a Pseudomonas strain against methicillin-resistant Staphylococcus aureus (MRSA) strains. Ann Clin Microbiol Antimicrob. 2013;12:12. doi:10.1186/1476-0711-12-1223773484
   PubMed Web of Science ®Google Scholar
• Palanisamy NK, Ferina N, Amirulhusni AN, et al. Antibiofilm properties of chemically synthesized silver nanoparticles found against Pseudomonas aeruginosa. J Nanobiotechnology. 2014;12:2. doi:10.1186/1477-3155-12-224422704
   PubMed Web of Science ®Google Scholar
• Scandorieiro S, De Camargo LC, Lancheros CAC, et al. Synergistic and additive effect of oregano essential oil and biological silver nanoparticles against multidrug-resistant bacterial strains. Front Microbiol. 2016;7. doi:10.3389/fmicb.2016.00760
   PubMed Web of Science ®Google Scholar
• Singh K, Panghal M, Kadyan S, Chaudhary U, Yadav J. Green silver nanoparticles of Phyllanthus amarus: as an antibacterial agent against multi drug resistant clinical isolates of Pseudomonas aeruginosa. J Nanobiotechnology. 2014;12(1):40. doi:10.1186/s12951-014-0040-x.25271044
   PubMedGoogle Scholar
• Morones JR, Elechiguerra JL, Camacho A, et al. The bactericidal effect of silver nanoparticles. Nanotechnology. 2005;16(10):2346–2353. doi:10.1088/0957-4484/16/10/05920818017
   PubMed Web of Science ®Google Scholar
• Lok C, Ho C, Chen R, et al. Proteomic analysis of the mode of antibacterial action of silver. J Proteome Res. 2006;5:916–924. doi:10.1021/pr050407916602699
   PubMed Web of Science ®Google Scholar
• Li P, Li J, Wu C, Wu Q, Li J. Synergistic antibacterial effects of β-lactam antibiotic combined with silver nanoparticles. Nanotechnology. 2005;16(9):1912–1917. doi:10.1088/0957-4484/16/9/082
   Web of Science ®Google Scholar
• Durán N, Durán M, de Jesus MB, Seabra AB, Fávaro WJ, Nakazato G. Silver nanoparticles: a new view on mechanistic aspects on antimicrobial activity. Nanomedicine. 2015;12(3):789–799. doi:10.1016/j.nano.2015.11.016.26724539
   PubMed Web of Science ®Google Scholar
• Herman A, Herman AP. Nanoparticles as antimicrobial agents: their toxicity and mechanisms of action. J Nanosci Nanotechnol. 2014;14(1):946–957. doi:10.1166/jnn.2014.8735.24730311
   PubMed Web of Science ®Google Scholar
• Seabra A, Durán N. Nanotoxicology of metal oxide nanoparticles. Metals (Basel). 2015;5(2):934–975. doi:10.3390/met5020934
   Web of Science ®Google Scholar
• Durán N, Nakazato G, Seabra AB. Antimicrobial activity of biogenic silver nanoparticles, and silver chloride nanoparticles: an overview and comments. Appl Microbiol Biotechnol. 2016;100(15):6555–6570. doi:10.1007/s00253-016-7657-727289481
   PubMed Web of Science ®Google Scholar
• Durán N, Seabra AB. Metallic oxide nanoparticles: state of the art in biogenic syntheses and their mechanisms. Appl Microbiol Biotechnol. 2012;95(2):275–288. doi:10.1007/s00253-012-4118-922639143
   PubMed Web of Science ®Google Scholar
• Ingale AG, Chaudhari AN. Biogenic synthesis of nanoparticles and potential applications: an eco- friendly approach. J Nanomed Nanotechnol. 2013;04(02). doi:10.4172/2157-7439.1000165
   Google Scholar
• Jelenko C. Silver nitrate resistant E. coli: report of case. Ann Surg. 1969;170(2):296–299. doi:10.1097/00000658-196908000-000214894351
   PubMed Web of Science ®Google Scholar
• Haefeli C, Franklint C, Hardy K, Biogen SA, Acacias R. Plasmid-determined silver resistance in Pseudomonas stutzeri isolated from a silver mine. J Bacteriol. 1984;158(1):389–392.6715284
   PubMed Web of Science ®Google Scholar
• McHugh GL, Hopkins CC, Moellering RC, Swartz MN. Salmonella typhymurium resistant to silver nitrate, chloramphenicol, and ampicillin. Lancet. 1975;305:235–240.
   Google Scholar
• Graves JL, Tajkarimi M, Cunningham Q, et al. Rapid evolution of silver nanoparticle resistance in Escherichia coli. Front Genet. 2015;5:1–13.
   Google Scholar
• Fayaz AM, Balaji K, Girilal M, Yadav R, Kalaichelvan PT, Venketesan R. Biogenic synthesis of silver nanoparticles and their synergistic effect with antibiotics: a study against gram-positive and gram-negative bacteria. Nanomedicine. 2010;6(1):103–109. doi:10.1016/j.nano.2009.04.00619447203
   PubMed Web of Science ®Google Scholar
• Jain J, Arora S, Rajwade JM, Omray P, Khandelwal S, Paknikar KM. Silver nanoparticles in therapeutics: development of an antimicrobial gel formulation for topical use. Mol Pharm. 2009;6(5):1388–1401. doi:10.1021/mp800174g19473014
   PubMed Web of Science ®Google Scholar
• Biasi-garbin RP, Otaguiri ES, Morey AT, et al. Effect of eugenol against Streptococcus agalactiae silver nanoparticles. Evid Based Complement Alternat Med. 2015;2015:1–8. doi:10.1155/2015/861497
   Web of Science ®Google Scholar
• Ghosh IN, Patil SD, Sharma TK, Srivastava SK, Pathania R, Navani NK. Synergistic action of cinnamaldehyde with silver nanoparticles against spore-forming bacteria: a case for judicious use of silver nanoparticles for antibacterial applications. Int J Nanomedicine. 2013;8:4721–4731. doi:10.2147/IJN.S3746524376352
   PubMed Web of Science ®Google Scholar
• Bocate KP, Reis GF, de Souza PC, et al. Antifungal activity of silver nanoparticles and simvastatin against toxigenic species of Aspergillus. Int J Food Microbiol. 2019;291:79–86. doi:10.1016/j.ijfoodmicro.2018.11.01230476736
   PubMed Web of Science ®Google Scholar
• Durán N, Marcato PD, Alves OL, De GIH, Esposito E. Mechanistic aspects of biosynthesis of silver nanoparticles by several Fusarium oxysporum strains. J Nanobiotechnology. 2005;7:1–7.
   Google Scholar
• Bauer AW, Kirby MWM, Jherris JC, Turck M. Antibiotic susceptibility testing by a standardized single disk method. Am J Clin Pathol. 1966;45:493–496. doi:10.1093/ajcp/45.6_ts.7645325707
   PubMed Web of Science ®Google Scholar
• CLSI. M100-S23 Performance Standards for Antimicrobial Susceptibility Testing; Vol 23; 2013.
   Google Scholar
• CLSI. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically. Vol. 32; 2012:69
   Google Scholar
• Kelly MT, Matsen JM. Testing parameters of amikacin, with comparisons to other aminoglycoside antibiotics in vitro activity, synergism, and testing parameters of amikacin, with comparisons to other aminoglycoside antibiotics. Antimicrob Agents Chemother. 1976;9(3):440–447. doi:10.1128/AAC.9.3.4401259402
   PubMed Web of Science ®Google Scholar
• Chin NX, Weitzman I. In vitro activity of fluvastatin, a cholesterol-lowering agent, and synergy with flucanazole and itraconazole against Candida species and Cryptococcus neoformans. Antimicrob Agents Chemother. 1997;41(4):850–852. doi:10.1128/AAC.41.4.8509087504
   PubMed Web of Science ®Google Scholar
• NCCLS. Methods for Determinating Bactericidal Activity of Antimicrobial Agents: Aproved Guideline. NCCLS, Vol. 19; 1999:50
   Google Scholar
• Izumi E, Veiga VF, Pinto AC, Nakamura CV. Terpenes from copaifera demonstrated in vitro antiparasitic and synergic activity. J Med Chem 2012;55(7):2994–3001. doi:10.1094/PDIS-11-11-0999-PDN
   Google Scholar
• Gonçalves A, Oliveira D, Sayuri L, et al. Evaluation of the antibiotic activity of extracellular compounds produced by the Pseudomonas strain against the Xanthomonas citri pv. Citri 306 Strain. Biol Control. 2011;56:125–131. doi:10.1016/j.biocontrol.2010.10.008
   Web of Science ®Google Scholar
• Abdoli N, Heidari R, Azarmi Y, Eghbal MA. Mechanisms of the statins cytotoxicity in freshly isolated rat hepatocytes. J Biochem Mol Toxicol. 2013;29(4):165–172.
   Google Scholar
• Çoban AY, Tekeli HO, Guney AK, Durupinar B. Investigation of the in vitro antibacterial effects of statins. Mikrobiyol Bul. 2010;161–163.20455414
   PubMed Web of Science ®Google Scholar
• Masadeh M, Mhaidat N, Alzoubi K, Al-azzam S, Alnasser Z. Antibacterial activity of statins: a comparative study of Atorvastatin, Simvastatin, and Rosuvastatin. Ann Clin Microbiol Antimicrob. 2012;11:1–5.22236533
   PubMed Web of Science ®Google Scholar
• Wang -C-C, Yang P-W, Yang S-F, Hsieh K-P, Tseng S-P, Lin Y-C. Topical simvastatin promotes healing of Staphylococcus aureus -contaminated cutaneous wounds. Int Wound J. 2015;1–10. doi:10.1111/iwj.1243125611693
   PubMed Web of Science ®Google Scholar
• Thangamani S, Mohammad H, Abushahba MFN, et al. Exploring simvastatin, an antihyperlipidemic drug, as a potential topical antibacterial agent. Sci Rep. 2015;5:1–13. doi:10.1038/srep16407
   Web of Science ®Google Scholar
• Kim JS, Kuk E, Yu N, et al. Antimicrobial effects of silver nanoparticles. Nanomedicine. 2007;3:95–101. doi:10.1016/j.nano.2006.12.00117379174
   PubMed Web of Science ®Google Scholar
• Mirzajani F, Ghassempour A, Aliahmadi A, Esmaeili MA. Antibacterial effect of silver nanoparticles on Staphylococcus aureus. Res Microbiol. 2011;162(5):542–549. doi:10.1016/j.resmic.2011.04.00921530652
   PubMed Web of Science ®Google Scholar
• Panacek A, Kvítek L, Prucek R, et al. Silver colloid nanoparticles: synthesis, characterization, and their antibacterial activity. J Phys Chem. 2006;33:16248–16253. doi:10.1021/jp063826h
   Google Scholar
• Pal S, Tak YK, Song JM. Does the antibacterial activity of silver nanoparticles depend on the shape of the nanoparticle? A study of the gram-negative bacterium Escherichia coli. J Biol Chem. 2015;290(42):1712–1720.25425642
   PubMedGoogle Scholar
• Bollenbach T. Antimicrobial interactions: mechanisms and implications for drug discovery and resistance evolution. Curr Opin Microbiol. 2015;27:1–9. doi:10.1016/j.mib.2015.05.00826042389
   PubMed Web of Science ®Google Scholar
• Fischbach MA. Combination therapies for combating antimicrobial resistance. Curr Opin Microbiol. 2011;14(5):519–523. doi:10.1016/j.mib.2011.08.00321900036
   PubMed Web of Science ®Google Scholar
• Stossel TP. The Discovery of Statins. BenchMarks. 2008;903–905.
   Google Scholar
• Kim SH, Lee HS, Ryu DS, Choi SJ, Lee DS. Antibacterial activity of silver-nanoparticles against Staphylococcus aureus and Escherichia coli. Korean J Microbiol Biotechnol. 2011;39(1):77–85.
   Google Scholar